Home/Filings/4/0001209191-17-022667
4//SEC Filing

ROCKWELL MEDICAL, INC. 4

Accession 0001209191-17-022667

$RMTICIK 0001041024operating

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 6:44 PM ET

Size

7.5 KB

Accession

0001209191-17-022667

Insider Transaction Report

Form 4
Period: 2017-03-21
Transactions
  • Award

    Common Stock

    2017-03-21+9,800115,550 total
Holdings
  • Common Stock

    (indirect: by Bagley & Langan P.L.L.C.)
    15,000
  • Common Stock

    (indirect: By Spouse)
    97,200
Footnotes (3)
  • [F1]Performance-based stock grant. This grant vests upon the earliest to occur of any of the following (a) reported net sales of the company in any four consecutive calendar quarters equals or exceeds $100,000,000, (b) the market capitalization of the company is greater than $600,000,000 for ten consecutive trading days, or (c) one year following the date the Centers for Medicare & Medicaid Services assign the company transitional add on reimbursement payment status for the drug product, Triferic.
  • [F2]The reporting person disclaims beneficial ownership of the common shares held by his spouse and this report should not be deemed an admission that the reporting person is the beneficial owner of his spouse's common shares for purposes of Section 16 or for any other purpose.
  • [F3]The reporting person disclaims beneficial ownership of the common shares held by the company and this report should not be deemed an admission that the reporting person is the beneficial owner of the company's common shares for purposes of Section 16 or for any other purpose. Mr. Bagley is the sole owner of Bagley & Langan, P.L.L.C.

Issuer

ROCKWELL MEDICAL, INC.

CIK 0001041024

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001041024

Filing Metadata

Form type
4
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 6:44 PM ET
Size
7.5 KB